Conference abstracts

twitter

more news

Childhood Cancer 2017

18th / 19th September, Newcastle
Two-day meeting focused on translational research for patient benefit.

register for updates

intro

Conference abstracts

 We called for abstracts for poster/oral presentation focused on the three conference themes:

  • Conference speakerPrecision medicine: Is precision medicine a reality for children with cancer in 2016?
  • Immunotherapy: Can we harness the power of the immune system to cure childhood cancer?
  • Causation: What do we know about influenceable causes of childhood cancer?

The accepted abstracts, along with abstracts from invited speakers, are available to download below.

red-dot Day 1: Is precision medicine a reality for children with cancer in 2016?

Chaired by Professor David Walker and Professor Louis Chesler
Invited speakers:

  • Professor Stefan Pfister: Is precision medicine a reality for children with cancer in 2016?
  • Professor Anthony Moorman: The genomic landscape of childhood leukaemia and options for precision therapy
  • Professor Richard Gilbertson: The successes and future direction of paediatric cancer research and therapy
  • Dr Darren Hargrave: Our initiatives and strategy to implement precision medicine in the UK

 View Day 1 abstracts [PDF]

red-dot Day 2: Can we harness the power of the immune system to cure childhood cancer?

Chaired by Professor Persis Amrolia and Professor John Anderson
Invited speakers:

  • Dr Nai-Kong Cheung: Antibody-based and Bispecific T-cell dependent therapies
  • Dr Stephan Grupp: The CAR T cell revolution in cancer therapy
  • Dr Daniel Lee: NCI CARs for childhood acute lymphoblastic leukaemia and neuroblastoma: the promise and potential pitfalls
  • Dr Martin Pule: Future approaches to engineering CAR T-cells

 View Day 2 abstracts [PDF]

red-dot Day 3: What do we know about influenceable causes of childhood cancer?

Chaired by Professor Denis Henshaw and Professor Tariq Enver
Invited speakers:

  • Professor Soterios Kyrtopoulos: Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project
  • Professor Tariq Enver: Origins and clonal evolution of childhood leukaemia
  • Dr Kurt Straif: What do we know about risk factors for childhood cancer and what are the challenges in ongoing research?
  • Dr Mark Miller : Primary prevention: Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers?

 View Day 3 abstracts [PDF]